The ASH choosing wisely® campaign: Five hematologic tests and treatments to question

Blood

Volumn 122, Issue 24, 2013, Pages 3879-3883

  Hicks, Lisa K ^a   Bering, Harriet ^b   Carson, Kenneth R ^c   Kleinerman, Judith ^d   Kukreti, Vishal ^e   Ma, Alice ^f   Mueller, Brigitta U ^g   O'Brien, Sarah H ^h   Pasquini, Marcelo ⁱ   Sarode, Ravindra ^j   Solberg Jr , Lawrence ^k   Haynes, Adam E ^l   Crowther, Mark A ^m  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b Washington University ^*

^c WASHINGTON UNIVERSITY   (United States)

^d Medical Specialists of Taunton   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h NATIONWIDE CHILDREN S HOSPITAL   (United States)

ⁱ MEDICAL COLLEGE OF WISCONSIN   (United States)

^j UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^k MAYO CLINIC   (United States)

^l Adam Haynes Consulting   (Canada)

^m MCMASTER UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; PROTHROMBIN COMPLEX;

BLOOD EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; ERYTHROCYTE TRANSFUSION; EVIDENCE BASED PRACTICE; HEALTH CARE COST; HEMATOLOGIST; HUMAN; NONHODGKIN LYMPHOMA; PLASMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THROMBOPHILIA; THROMBOSIS; TOTAL QUALITY MANAGEMENT; VENA CAVA FILTER;

EID: 84891119402     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-07-518423     Document Type: Review

References (41)

1. Miyakis S, Karamanof G, Liontos M, Mountokalakis TD. Factors contributing to inappropriate ordering of tests in an academic medical department and the effect ofeducational feedback strategy. Postgrad Med J. 2006;82(974):823-829
2. Smith MD. Institute of Medicine (U.S.). Committee on the Learning Health Care System in America. Best care at lower cost: the path to continuously learning health care in America.Washington, DC: National Academies Press; 2012
3. Billi JE, Duran-Arenas L, Wise CG, Bernard AM, McQuillan M, Stross JK. The effects of a low-cost intervention program on hospital costs. J Gen Intern Med. 1992;7(4):411-417
4. Jones J, Hunter D. Consensus methods for medical and health services research. BMJ. 1995; 311(7001):376-380
5. Zelenetz AD, Wierda WG, Abramson JS, et al. Non-Hodgkin's lymphomas, version 1.2013. J Natl Compr Canc Netw. 2013;11(3):257-272; quiz 273
6. Tilly H, Dreyling M. Diffuse large B-cell non- Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(Suppl 5):v172-174
7. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer carein the United States: 2010-2020. J Natl Cancer Inst. 2011;103(2):117-128
8. Tangka FK, Trogdon JG, Richardson LC, Howard D, Sabatino SA, Finkelstein EA. Cancer treatment cost in the United States: has the burden shifted over time? Cancer. 2010;116(14):3477-3484
9. Experts in Chronic Myeloid Leukemia. The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts. Blood. 2013;121(22):4439-4442
10. Napolitano LM, Kurek S, Luchette FA, et al. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. J Trauma. 2009;67(6):1439-1442
11. Carson JL, Grossman BJ, Kleinman S, et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2012;157(1): 49-58
12. Retter A, Wyncoll D, Pearse R, et al. Guidelines on the management of anaemia and red cell transfusion in adult critically ill patients. Br J Haematol. 2013;160(4):445-464
13. Dutch Institute for Healthcare Improvement CBO. Blood transfusion guideline. Available from: http://www.sanquin.nl/en/productsservices/ bloodproducts/transfusionguideline/. Accessed January 10, 2013.
14. Toward Optimized Practice. Guideline for red blood and plasma transfusion: a summary. Available from: http://www.topalbertadoctors.org/cpgs. php. Accessed January 10, 2013
15. Chong LY, Fenu E, Stansby G, Hodgkinson S. Management of venous thromboembolic diseases and the role of thrombophilia testing: summary of NICE guidance. BMJ. 2012;344:e3979
16. Baglin T, Gray E, Greaves M, et al. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol. 2010;149(2):209-220
17. Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl): e419S-494S
18. Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl): e227S-277S
19. Kearon C, Julian JA, Kovacs MJ, et al. Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial. Blood. 2008;112(12): 4432-4436
20. Sarosiek S, Crowther M, Sloan JM. Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level 1 trauma center. JAMA Intern Med. 2013;173(7):513-517
21. Dupras D BJ, Felty C, et al Institute for Clinical Systems Improvement. Venous thromboembolism diagnosis and treatment.Available from: http://bit.ly/VTE0113. Accessed: January 12, 2013
22. National Clinical Guideline Center. Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing. Available from: http://www.ncbi.nlm.nih.gov/books/NBK132796/. Accessed January 13, 2013
23. Jaff MR, McMurtry MS, Archer SL, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011;123(16):1788-1830
24. Stein PD, Kayali F, Olson RE. Twenty-one-year trends in the use of inferior vena cava filters. Arch Intern Med. 2004;164(14):1541-1545
25. Birkmeyer NJ, Share D, Baser O, et al. Preoperative placement of inferior vena cava filters and outcomes after gastric bypass surgery. Ann Surg. 2010;252(2):313-318
26. Angel LF, Tapson V, Galgon RE, Restrepo MI, Kaufman J. Systematic review of the use of retrievable inferior vena cava filters. J Vasc Interv Radiol. 2011;22(11):1522-1530 e1523
27. Holbrook A, Schulman S, Witt DM, et al. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl): e152S-184S
28. Scottish Intercollegiate Guidelines Network (SIGN). Antithrombotics: indications and management. Available from: http://www.sign.ac.uk. Accessed: January 10, 2013.
29. Crowther MA, Garcia D, Ageno W, et al. Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10. Thromb Haemost. 2010;104:118-21
30. Sarode R, Rawal A, Lee R, et al. Poor correlation of supratherapeutic international normalized ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy. Br J Haematol. 2006;132:604-607
31. Shenoy P, Sinha R, Tumeh JW, Lechowicz MJ, Flowers CR. Surveillance computed tomography scans for patients with lymphoma: is the risk worth the benefits?. Clin Lymphoma Myeloma Leuk. 2010;10(4):270-277
32. American Society of Clinical Oncology. Five things physicians and patients should question. Available from: http://www.asco.org/sites/default/ files/5things12factsheet.pdf. Accessed June 10, 2013.
33. Guppy AE, Tebbutt NC, Norman A, Cunningham D. The role of surveillance CT scans in patients with diffuse large B-cell non-Hodgkin's lymphoma. Leuk Lymphoma. 2003;44(1):123-125
34. Lin TL, Kuo MC, Shih LY, et al. Value of surveillance computed tomography in the followup of diffuse large B-cell and follicular lymphomas. Ann Hematol. 2012;91(11):1741-1745
35. Weeks JC, Yeap BY, Canellos GP, Shipp MA. Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission. J Clin Oncol. 1991;9(7):1196-1203
36. Elis A, Blickstein D, Klein O, Eliav-Ronen R, Manor Y, Lishner M. Detection of relapse in non-Hodgkin's lymphoma: role of routine follow-up studies. Am J Hematol. 2002;69(1):41-44
37. Liedtke M, Hamlin PA, Moskowitz CH, Zelenetz AD. Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population. Ann Oncol. 2006;17(6):909-913
38. Brenner DJ, Hall EJ. Computed tomography-an increasing source of radiation exposure. N Engl J Med. 2007;357:2277-2284
39. Society of Hospital Medicine. Five things physicians and patients should question. Available from: http://www.hospitalmedicine.org/AM/pdf/SHM-Adult- 5things-List-Web.pdf. Accessed June 10, 2013
40. American College of Radiology. Five things physicians and patients should question. Available from: http://www.choosingWisely.org/doctorpatient-lists/ american-college-of-radiology/. Accessed June 10, 2013.
41. Parker A BB, Devereux S, Gatter K, Jack A, Matutes E, et al. Best practice in lymphoma diagnosis and reporting. British Committee for Standards in Haematology and the Royal College of Pathologists. Available from: http://www.bcshguidelines.com. Accessed January 12, 2013